BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 30 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $24,014 | +46080.8% | 72,770 | 0.0% | 0.00% | – |
| Q4 2022 | $52 | -99.9% | 72,770 | -0.2% | 0.00% | – |
| Q3 2022 | $87,000 | +1.2% | 72,925 | 0.0% | 0.00% | – |
| Q2 2022 | $86,000 | -45.2% | 72,925 | 0.0% | 0.00% | – |
| Q1 2022 | $157,000 | +45.4% | 72,925 | 0.0% | 0.00% | – |
| Q4 2021 | $108,000 | -51.6% | 72,925 | -4.7% | 0.00% | – |
| Q3 2021 | $223,000 | +15.5% | 76,533 | +30.5% | 0.00% | – |
| Q2 2021 | $193,000 | +63.6% | 58,659 | +86.8% | 0.00% | – |
| Q1 2021 | $118,000 | +7.3% | 31,400 | 0.0% | 0.00% | – |
| Q4 2020 | $110,000 | -62.6% | 31,400 | -30.0% | 0.00% | – |
| Q3 2020 | $294,000 | -11.4% | 44,864 | +0.3% | 0.00% | – |
| Q2 2020 | $332,000 | +74.7% | 44,750 | +8.7% | 0.00% | – |
| Q1 2020 | $190,000 | – | 41,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 159,500 | $563,000 | 0.11% |
| Ikarian Capital, LLC | 500,000 | $1,765,000 | 0.08% |
| Anson Funds Management LP | 99,103 | $350,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 66,558 | $235,000 | 0.04% |
| AJU IB Investment Co., Ltd. | 25,651 | $91,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 53,041 | $187,000 | 0.01% |
| SHUFRO ROSE & CO LLC | 12,941 | $46,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $879,000 | 0.00% |
| Tekla Capital Management LLC | 6,000 | $21,000 | 0.00% |
| Orion Capital Management LLC | 500 | $2,000 | 0.00% |